I would be very cautious to say the entire infectious disease testing sector. There are major PCR based commercial tests (for infections) which are well established, high volume and routine and can't be replaced by 3-base method. Regarding cancer screening, I don't think 3-base method is effective.
I would be very cautious to say the entire infectious disease...
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add GSS (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
68.0¢ |
Change
0.005(0.74%) |
Mkt cap ! $155.4M | |||
| Open | High | Low | Value | Volume |
| 70.0¢ | 70.0¢ | 67.5¢ | $16.68K | 24.27K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 27724 | 67.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 70.0¢ | 15574 | 2 |
View Market Depth
| Last trade - 14.24pm 03/12/2024 (20 minute delay) ? |
| GSS (ASX) Chart |
